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Abstract
Background: We describe the development, validation, and use of a highly redundant 120,000
oligonucleotide microarray (MuscleChip) containing 4,601 probe sets representing 1,150 known
genes expressed in muscle and 2,075 EST clusters from a non-normalized subtracted muscle EST
sequencing project (28,074 EST sequences). This set included 369 novel EST clusters showing no
match to previously characterized proteins in any database. Each probe set was designed to contain
20–32 25 mer oligonucleotides (10–16 paired perfect match and mismatch probe pairs per gene),
with each probe evaluated for hybridization kinetics (Tm) and similarity to other sequences. The
120,000 oligonucleotides were synthesized by photolithography and light-activated chemistry on
each microarray.
Results:  Hybridization of human muscle cRNAs to this MuscleChip (33 samples) showed a
correlation of 0.6 between the number of ESTs sequenced in each cluster and hybridization
intensity. Out of 369 novel EST clusters not showing any similarity to previously characterized
proteins, we focused on 250 EST clusters that were represented by robust probe sets on the
MuscleChip fulfilling all stringent rules. 102 (41%) were found to be consistently "present" by
analysis of hybridization to human muscle RNA, of which 40 ESTs (39%) could be genome anchored
to potential transcription units in the human genome sequence. 19 ESTs of the 40 ESTs were
furthermore computer-predicted as exons by one or more than three gene identification
algorithms.
Conclusion:  Our analysis found 40 transcriptionally validated, genome-anchored novel EST
clusters to be expressed in human muscle. As most of these ESTs were low copy clusters (duplex
and triplex) in the original 28,000 EST project, the identification of these as significantly expressed
is a robust validation of the transcript units that permits subsequent focus on the novel proteins
encoded by these genes.
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Background
There are three platforms used for expression profiling
with microarrays: spotted cDNA arrays [1,2], spotted oli-
gonucleotide arrays [3], and in situ synthesized oligonu-
cleotide arrays (Affymetrix) [4]. There are inherent
advantages and disadvantages to each approach. Spotted
arrays (both cDNA and oligonucleotide) are more easily
customizable and can be considerably less expensive to
produce and use. However, the manipulation of many
thousands of solutions has led to contamination prob-
lems with commercially available clone sets [5]. The in-
herent flexibility of the spotted microarrays has the added
liability of difficulties in standardization of arrays and ar-
ray data; the resulting data is not considered highly trans-
portable [6].
Affymetrix arrays are produced directly from nucleotide
sequences in databases, and do not include any liquid
handling of specific clones. 25 mer oligonucleotides are
designed against selected genes/ESTs as perfect-match and
mis-match probe pairs tiled across each gene, with subse-
quent in situ synthesis of each probe set on a solid glass
support. This bio-informatics-driven probe design and
probe sequence extraction process, combined with the
photolithographic probe synthesis method, provides
standardized arrays, with resulting data that is inherently
transportable. Typically, 30–40 probes are synthesized per
gene, and the highly redundant data allows the imple-
mentation of algorithms that computationally compen-
sate for cross hybridization, experimental variability
across a surface, and poorly performing probes. An advan-
tage of the factory-produced Affymetrix GeneChips is that
they are inherently standardized, and thus permit easy
comparisons between profiles using the same chip. How-
ever, this is also a disadvantage, as chip design and pro-
duction of novel photolithography arrays is quite labor
intensive and expensive. Indeed, most reports to date have
utilized only "stock chips" produced and marketed by Af-
fymetrix (see  [www.affymetrix.com]), with little flexibili-
ty as to the specific genes under study.
Here, we describe the design, production, and use of a cus-
tom Affymetrix array, based upon a non-normalized EST
sequence resource from human skeletal muscle [7], with
additional probe sets selected from preliminary data on
human muscle using Affymetrix stock chips [8]. A goal of
producing the described MuscleChip was to use expres-
sion profiling as a means of validating novel ESTs. It is
commonly acknowledged that ESTs represented by only
singletons or small clusters in dbEST may represent arti-
fact, and thus require verification. We felt that the robust
analytical protocol of Affymetrix chips would permit accu-
rate verification of large numbers of potentially novel
ESTs in a highly parallel manner.
Results
Design and production of custom Affymetrix MuscleChip
Three resources were used to select probe sets for the Mus-
cleChip: a non-normalized muscle EST resource [7], "diff
calls" from stock chip (Affymetrix HuFL) comparisons of
normal and Duchenne muscular dystrophy muscle [8],
and 172 gene sequences of interest from a number of in-
vestigators in muscle research (Table 1). From the EST re-
source, approximately 30,000 3' ESTs were sequenced
from a non-normalized normal human muscle cDNA li-
brary ([7]; and unpublished), and sequences resolved into
2,052 clusters which were placed onto the MuscleChip.
From the normal/DMD HuFL data, 1,120 genes were se-
lected as showing significant differences between normal
and dystrophic muscle. Of these 1,120 probe sets 1,052
were drawn directly from the Affymetrix HG-U95A stock
chip, and the remaining 68 probe sets were drawn from
the original HuFL chip. The lists of genes from these three
sources were combined and then resolved into 4,601
probe sets representing 3,344 sequences that were chosen
from the different sources. Many of the genes/ESTs were
designed with multiple probe sets to enable intra-chip ver-
ification of expression data (Table 1); the redundant
probe sets included _at (complete rule set; default probe
set), _f (functional consensus), _g (possible cluster
group), _i (incomplete set), _r (rules dropped), and _s
(similar to other clusters/sequences) (See Methods, Musc-
leChip production).
The MuscleChip was originally designed with 2,052 EST
sequences, 734 of which showed no match with UniGene
clusters using 1999 builds. To update the sequence defini-
tions, those EST clusters or singletons previously showing
no high similarity to databases were BLAST searched
against the most recent nr database release, using the Net-
Blast stand alone search tool (Table 2). There were only 26
EST clusters that showed no high similarity in either
cDNA/RNA sequence resources, or genomic DNA resourc-
es, with an additional 343 clusters showing homology to
non-characterized genomic or EST cluster sequence data
(Table 2). 365 sequences showed highly significant align-
ments with recently characterized proteins, which were
then updated in the sequence definition file  [http://
microarray.cnmcresearch.org/musclechipindex.asp].
Validation of MuscleChip
To verify the MuscleChip, we used the same biotinylated
cRNA that we had recently reported from muscular dystro-
phy patients and normal controls [8]. These pooled sam-
ples were derived from 5 Duchenne muscular dystrophy
patients and 5 age and sex-matched controls, as we have
previously described [8]. The same hybridization solu-
tions were applied to both MuscleChips and to the Af-
fymetrix HG-U95A human stock GeneChip, and the
results compared. Two profiles of each mixed sample wereBMC Bioinformatics 2002, 3 http://www.biomedcentral.com/1471-2105/3/33
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generated from different aliquots of RNA, derived from
different regions of the biopsies, for a total of four HG-
U95A profiles, and four MuscleChip profiles. Fluorescent
images were scaled to target intensity of 800. Scaling fac-
tors for the MuscleChip (0.7–1.17) were similar to HG-
U95A (0.78–1.67). "Present calls", which are generally in-
dependent of scaling factors, were approximately 25–30%
of genes on the HG-U95A, and approximately 40–50% of
genes on the MuscleChip. This reflects the greater repre-
sentation of muscle-specific transcripts on the Muscle-
Chip, relative to HG-U95A.
We then compared profiles for the same cRNA hybridiza-
tion sample on the MuscleChip and HG-U95A stock
chips. The correlation between replicate samples (Con1
and Con2) on the HG-U95A and the MuscleChip for
1,052 shared probe sets was 0.98 and 0.99 respectively
(data not shown). The high reproducibility of Affymetrix
stock chip and MuscleChip results is consistent with other
data in our laboratory [14].
Absolute intensities (Avg Diff) for each probe set shared
between the two chips were plotted against each other, us-
ing both "absent" and "present" calls (Figure 1. Panel A;
Data Analysis in Methods). Overall, there was an excellent
correlation between values for the two different chips, ver-
ifying the performance of the MuscleChip (correlation co-
efficient, r = 0.89).
From the graph in Figure 1, the slope of the comparison
of shared probe sets in HG-U95A vs. the MuscleChip de-
viated from 1. This was due to the fact that the Muscle-
Chip was partially constructed from probe sets on the
HuFL chip showing high expression in muscle. This leads
to a type of ascertainment bias, where the overall hybridi-
zation to the MuscleChip is higher than U95A, given the
same amount of muscle cRNA hybridized to the chip. To
correct for this, one simply takes shared probe sets, and
considers the Avg Diff (hybridization intensities) equal
between the two array types (e.g. normalize data using
shared genes, rather than a fixed target intensity). This
leads to a MuscleChip-specific scaling factor, that, when
applied, makes U95A and MuscleChip results directly
comparable (Figure 1, panel B). This MuscleChip-target
intensity was 800 times 3.18 (target intensity of 1970 for
MuscleChip = target intensity of 800 for U95A).
Table 1: Sequences and probe sets on the MuscleChip
Sequences Chosen
2,052 ESTs & 172 collaborator sequences (custom): 2,224
U95A sequences (commercial): 1,052
Hu6800/HuFL sequences (commercial): 68
Total custom and commercial sequences: 3,344
Sequences and probe sets on the MuscleChip:
Total number of probe sets on the Muscle Chip: 4,601
Total number of custom and commercial sequences: 3,344
Redundancy within sequence representation (custom set):
sequences represented by 1 probe set: 1,209
sequences represented by 2 probe sets: 773
sequences represented by 3 probe sets: 242
Table 2: Distribution of BLAST results of 734 novel ESTs on MuscleChip. BLAST search with 734 query EST sequences
No high similarity found in either RNA or genomic DNA: 26
No match to known gene. but matches to undefined genomic or EST sequences: 343
Total number of non hits 369
Significant alignments with following distribution:
- Low significant matches: 10
- High significant matches:
- Matches to ref 291
- Matches to emb 14
- Matches to gb 50
Total number of hits: 365
Total number of sequences 734BMC Bioinformatics 2002, 3 http://www.biomedcentral.com/1471-2105/3/33
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Figure 1
Validation of MuscleChip by comparison to shared probe sets on HG-U95A stock chip, and the chip to chip
variability of custom probe sets on the MuscleChip. Panel A. Shown is correlation of absolute analysis values (Avg Diff)
for probe sets shared by the two chips, after hybridization with the same human normal muscle cRNA. There is an excellent
correlation coefficient (0.89) between the two chips, although there is evidence of saturation of the HG-U95 chip for more
abundant cRNAs. Panel B. Shown is the same data as in Panel A, but with removal of potentially saturated probe sets, and after
adjustment for different scaling factors (MuscleChip Avg Diff times 3.18). A correlation coefficient of 0.89 is observed.
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Another difference between the MuscleChip and U95A
data is seen for probe sets with the highest levels of hy-
bridization; namely, a plateau effect for HG-U95A, while
values continued to increase for the MuscleChip (Figure 1.
Panel A). This increased dynamic range was attributed to
newer production facilities used for the MuscleChip, with
greater numbers of oligos successfully synthesized in each
feature.
As a second form of validation, we compared "present"
and "absent" calls for the same probe sets, using the same
cRNA, on both the MuscleChip and HG-U95A, using both
MAS 4 (data above), and the newly released MAS 5 ver-
sions of the Affymetrix algorithms. MAS 5 also has the ad-
vantage of eliminating negative Avg Diff values, and
replacing them with simpler positive value signal metrics.
Using MAS 4, the large majority (95%) of the 1,052 probe
sets shared between the two chips showed the same "call",
and also showed excellent correlation between absolute
intensities. Using MAS 5, the number of present calls de-
creased for both U95A and MuscleChip; this is expected
given the greater stringency of the newer algorithms for
transcripts expressed at low levels, and thus fewer expect-
ed "false positive" present calls. This analysis showed a de-
crease in the number of "present" calls from 5,110
assigned by MAS4 to 4,427 "present" calls assigned by
MAS5, of which 4,284 "present" calls were assigned by
both algorithms. However, the correlation coefficient be-
tween the signal values obtained by the two algorithms
was as high as 0.95. The high correlation between the av-
erage intensity signal obtained by the two algorithms sup-
ports the expected reduced number of false "present"
calls. The increased stringency is also supported by the fact
that 97% of the "present" calls detected by MAS5 is detect-
ed by MAS4, but only 87% of "the present" calls detected
by MAS4 is also detected by MAS5. The balance between
the number of false and true "present" calls is directly in-
fluenced by the balance between stringency and sensitivi-
ty that can be modified in the MAS5 software. Although
the detection calls assigned by the MAS5 algorithms were
somewhat different from the calls assigned by the MAS4
software it did not affect the correlations between the
shared probe sets on HG-U95A and the MuscleChip. The
correlation coefficient between shared probe sets on the
HG-95A and the MuscleChip was 0.89 and 0.87 for the
MAS 4 and MAS 5 analysis, respectively.
Correlation of EST clone number with absolute intensity 
(Avg Diff)
Clone EST number (clone frequency) in EST sequencing
projects of non-normalized cDNA libraries is often con-
sidered to reflect the relative abundance of the transcript
(e.g. "virtual Northerns" in dbEST). We hypothesized that
hybridization intensities on the redundant Affymetrix
GeneChip platform could provide a second means of
studying relative transcript abundance. Such correlations
are difficult with Affymetrix stock chips, as the probe sets
are not derived from a specific non-normalized EST
source, and correlations of EST number in specific dbEST
cDNA libraries would be problematic. Furthermore, the
majority of EST sequencing projects have used normalized
or highly subtracted libraries.
As we had printed a large number of EST clusters from a
non-normalized normal muscle EST data set on the Mus-
cleChip, we selected the subset of probe-sets from this EST
database, and correlated the number of clones in each EST
cluster with the absolute intensities after hybridization to
normal muscle. Two datasets were used in this analysis;
one set from hybridization of pooled muscle samples
from normal 6–9 years old boys as described previously
[8], and one data set consisting of the average value of the
hybridization intensities obtained from hybridizations to
the MuscleChip with six individual samples from normal
adults.
We found a reasonable correlation between clone number
and Avg Diff values using the pooled samples described
before [8], with a correlation coefficient of 0.67 (Figure 2,
Panel A), and a slightly lower degree of correlation using
the averaged intensity from the individual experiments,
with a correlation coefficient of 0.6 (Figure 2, Panel B).
To determine possible explanations for "outliers" be-
tween clone number and Avg Diff, we examined 11 differ-
ent outliers (chosen by visual inspection), as indicated in
Figure 2, panel A. ESTs 1 through 8 showed a very high ex-
pression level by hybridization, yet a low EST clone
number (Figure 2, Panel A). Seven of the eight high out-
liers corresponded to probe sets that were designed as ei-
ther _f or _s probe sets, indicating high homology to
additional EST clusters. Thus, these probes would typical-
ly be expected to show a high degree of cross hybridiza-
tion to additional similar genes and ESTs. We therefore
conclude that these outliers likely result from cross-hy-
bridization to more abundant clusters.
We also investigated three "low" outliers, where clone
number was unexpectedly high relative to absolute inten-
sity (Avg Diff). All of these low-value outliers were _i and
_r probe sets, which typically would be expected to show
poor hybridization compared to _at-only probe sets. Thus
the low hybridization was explained by "incomplete" and
"rules dropped" probe set design for these particular
probe sets. This data suggests that analysis is more accu-
rate and reproducible if limited to _at probe sets; this is
also acknowledged on Affymetrix stock GeneChips.
We then restricted the analysis of the averaged non-
pooled samples (Figure 2, Panel B) to _at only probe set,BMC Bioinformatics 2002, 3 http://www.biomedcentral.com/1471-2105/3/33
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Figure 2
EST cluster member number correlation with hybridization intensity (Avg Diff) on the MuscleChip. Panel A.
Shown is a log-linear scatter plot of Avg Diff (expression level of each RNA given by normalized hybridization intensity on the
MuscleChip) versus the relative percentage of EST cluster members in a non-normalized normal muscle EST sequencing
project (n-EST/cluster in 28,074 sequenced clones). The number of unique EST clusters shown is 2,052. The correlation coeffi-
cient of the log-linear regression is 0.67 indicating that, on average, there is a relationship between EST cluster member
number and hybridization intensity. A small number of "outliers" from this analysis are indicated and numbered as described in
the Results. The large majority of these outliers correspond to non-(_at) probe sets, where probe set design rules were
altered or dropped. Thus, most outliers are likely due to cross-hybridization to other mRNA species. Panel B. Shown is a log-
linear scatter plot of the average absolute intensity of six individual profiles (y-axis: average Avg Diff) versus the relative per-
centage of EST cluster members (x-axis: relative percentage of 28,074 on log10 scale) in a non-normalized normal muscle EST
sequencing project. The number of unique EST clusters shown is 2,052. The correlation coefficient of the log-linear regression
is 0.6 showing a correlation between number of sequences in EST clone and the averaged absolute intensity of individual sam-
ples hybridized to the MuscleChip. High outliers are non _at only probe sets. Panel C. Shown is a log-linear scatter plot of the
average absolute intensity of six individual profiles (y-axis: average Avg Diff) versus the relative percentage of EST cluster mem-
bers (x-axis: relative percentage of 28,074 on log10 scale) in a non-normalized normal muscle EST sequencing project. The EST
clusters shown are reduced to ideal (_at only) probe sets. The correlation coefficient of the log-linear regression is 0.6. The
difference in sensitivity between the two techniques may contribute to lower linear correlation in the intermediate and high
abundant transcripts giving a correlation coefficient of 0.6 identical to the correlation when the non-ideal probe sets are
included.
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which showed an identical level of correlation with a cor-
relation coefficient of 0.6 (Figure 2, Panel C). Indeed, the
_at data shown in Figure 2, Panel C show neither high out-
liers for clones with low EST number or low outliers for
clones with high EST numbers, suggesting that the design
of "ideal" probe sets improves performance (specificity
and sensitivity) as expected. Our data does not address the
issue of whether EST clone number or hybridization in-
tensity (Avg Diff chip values) is, or is not, a more accurate
reflection of "true" transcript abundance.
Correlation of low abundance ESTs with "present" calls
To determine if low abundance ESTs (singletons. or du-
plex and triplex clusters) from a muscle EST sequencing
project could be verified using expression profiling, we
correlated the cluster member number (n-EST) with
"present", "marginal" and "absent" calls using Affymetrix
default interpretations of probe set hybridization patterns
(Figure 3). For 777 clusters with 1, 2 or 3 EST clone mem-
bers, we found 68% of triplex clusters to be "present" or
"marginal", 46% of duplex clusters, and 30% of single-
tons (Figure 3, Panel A). Thus, there was a clear correla-
tion between the clone number for relatively rare
transcripts, and the ability of the custom probe sets on the
MuscleChip to identify these transcripts as "present" calls
based on hybridization of normal muscle cRNA (Figure 3,
Panel A).
Use of the MuscleChip for verification of expression of 
anonymous ESTs
As the sequence list used to design and produce the Mus-
cleChip was about a year old by the time of application,
we updated all sequence definitions (Table 2), and then
focused further analysis on expression data for the 369
novel EST clusters that showed no significant match to
characterized genes (no name or function assigned, and
no high homology to genes with function assigned). From
these 369 novel EST clusters, 605 probe sets had been de-
signed and printed. However, we were able to design
probe sets fulfilling all rules (e.g. _at probe sets) for only
250/369 (68%) of the novel sequences, due to the limit-
ing amount of sequence data for many of the singletons/
clusters with low member number (Table 4). Of the 605
probe sets studied (all types), 285 were seen one or more
times as "present" in the four profiles used for validation
of the MuscleChip (pooled samples [8]). These 285 probe
sets indicate that the corresponding genes are likely truly
expressed in muscle, however this set included probe sets
that could possibly cross-hybridize to other sequences
(e.g. _g. _s. etc.; see Methods). Limiting this analysis to
only probe sets fulfilling all stringency rules for unique
probe set design (_at probe sets), we found 114 of 250
(46%) as "present" calls in all four profiles (Table 4).
Thus, 114 novel EST clusters/singletons have a very high
likelihood to be expressed in human muscle and repre-
sent novel expressed genes.
We correlated the 114 novel "present" calls with n-EST,
and found that 89/114 (78%) were from clusters with
only two or three members (duplex, triplex clusters) (data
not shown). The lack of singletons in this set is due to the
inability to design complete, non-overlapping, unique
probe sets fulfilling all rules with only ~250 bp of se-
quence in these singletons.
Since we have shown that a correlation between low
abundance transcripts and "present" calls exists (Figure 3,
Panel A), we wanted to assess the correlation using only
the subset of 250 EST with _at probe sets that showed no
match to a characterized gene or protein, when analyzed
by BLAST (Table 4). Out of these 250 ESTs, 195 EST clus-
ters had 2, 3 or 4 EST clone members (Table 3). We found
81% of quadruple clusters to be "present" or "marginal",
72% of triplex clusters, and 45% of duplex (Figure 3, Pan-
el B; Table 3), which clearly shows an increase in "present
" calls with clone number.
To assign a higher level of confidence to the set of 369
novel expressed transcripts (novel hit EST clusters), the
250 ESTs associated with _at only probe sets were
screened by "present" call in all of four profiles (pooled
normal muscle [8]). Of the 114 ESTs that were selected in
this fashion, the 102 that showed similarity to genomic,
mRNA or hypothetical protein (RefSeq database) were
queried against the Human Genome draft sequence by the
BLAST-Like Alignment Tool (BLAT) algorithm using the
Human Genome browser at UCSC  [http://www.ge-
nome.ucsc.edu/][12,13]. BLAT alignments of length great-
er than 40 bases and identity higher than 95% were
retained (Table 5). For each EST query the genomic se-
quences (BAC clone, contig or working draft clone) that
the EST aligned to in either the BLAST or BLAT search is
shown, as are BLAT identity and chromosome match for
the best alignments (Table 5; for both best and the next
best alignments see Additional File 1 – Table 1). Hypo-
thetical protein mRNA hits from the RefSeq database were
identified by BLAST search for 40 of the 102 ESTs and ac-
cession number is shown (Table 5; See additional file 1,
Table 1, for table containing hotlinks to GenBank – ENT-
REZ at NCBI). 19 of the 40 RefSeq BLAST sequences did
not match by BLAT search to the Genome Browser and the
accession numbers are shown in parentheses (Table 5).
The letters A, E, F, G in the gene prediction column indi-
cates when one or more gene prediction programs have
predicted a coding region or exon where the EST is aligned
to the human genome sequence (see Methods, Validation
of non characterized ESTs).BMC Bioinformatics 2002, 3 http://www.biomedcentral.com/1471-2105/3/33
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Further support for the transcription of these 102 genes in
muscle was provided by the analysis of an additional 33
MuscleChip expression profiles of human muscle (Table
5). Data on expression level, the average normalized hy-
bridization intensity (Avg Diff) and the percentage of
"present" and "marginal" calls of the 33 profiles are pre-
sented (Table 5). Similarly to previous described results
(Figure 3, Panel A and Panel B) there was a correlation be-
tween Avg Diff hybridization intensities and percentage of
"present" calls, with the higher Avg Diff values showing
higher percentage of "present" calls (Table 5). This data
provides robust verification of the expression of these 102
ESTs in human muscle with 40 ESTs genome anchored to
transcriptional units by BLAT and BLAST search. The BLAT
analysis also assigns priority of ESTs that maps to multiple
regions of the genome by percent identity, suggesting that
most multiple hits is a result of existence of pseudo genes
or closely related gene families.
Figure 3
Hybridization to probe sets on the MuscleChip provides verification of singleton, and other low member EST
clusters. Panel A. Graph output from "the Vertical Line" program showing unique EST singletons or clusters (duplex, or tri-
plex) as individual lines emanating from the left axis (777 clusters total). Probe sets were designed for each cluster on the Mus-
cleChip, and normal muscle cRNA hybridized to the MuscleChip. Using default Affymetrix algorithms, hybridization pattern to
each probe set were assigned as "present" (red lines), "marginal" (yellow lines), or "absent" (black lines) (See Methods). There
is a clear correlation with definition of "present" calls and EST cluster member number (see also Table 3). This result shows
that 30% of EST singletons were verified as "present" in normal muscle RNA by this method. Panel B. Shown is a subset of EST
that showed no match to a known gene, when analyzed by BLAST (Table 4). As in Panel A, "the Vertical line Program" is used
to map the absolute intensity to clone number in EST cluster, using the default Affymetrix algorithms and hybridization pattern
to assign each probe set a call as "present" (red lines), "marginal" (yellow lines), or "absent" (black lines). Out of 250 ESTs, 195
EST clusters had 2, 3 or 4 EST clone members. We found 81% of quadruple clusters to be "present" or "marginal", 72% of tri-
plex clusters, and 45% of duplex showing increase in "present " calls with clone number.
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Discussion
Muscle is an ideal tissue for expression profiling in hu-
mans, as it is relatively easily accessible from both normal
volunteers and neuromuscular disease patients, biopsied
in relatively large quantities, and prepared for pathology
in a manner that is ideal for expression profiling. Howev-
er, the relatively poor sensitivity and specificity of existing
expression profiling resources for human muscle are a
limiting factor in conducting profiling experiments. In ad-
dition, muscle shows very highly specialized cell-type-spe-
cific expression of highly related gene families, where
isoforms of specific proteins may differ by only a few ami-
no acids. Thus, use of probe sets completely specific for in-
dividual gene family members is critical if the muscle
transcriptome is to be understood (particularly with re-
gards to different types of muscle conditioning/exercise).
For these reasons, we sought to create an expression pro-
filing resource that would give good sensitivity and specif-
icity for human muscle. We designed the MuscleChip so
that it would provide good sensitivity in normal adult
muscle for exercise and atrophy studies in volunteers
(2,052 EST clusters from normal muscle), and pathologi-
cal muscle (1,120 genes from differentially regulated
genes in dystrophic muscle; [8]) (Table 1). We designed
and printed 4,601 probe sets representing 3,344 unique
genes/ESTs, and then validated this MuscleChip by com-
parison to HG-U95A GeneChip profiles. The MuscleChip
appeared to have a greater dynamic range than the HG-
U95A stock chip (Figure 1), despite the fact that they both
shared the same feature size and synthesis methods. We
also found that the typical target intensity of 800 used for
whole-chip normalization of most Affymetrix stock chips
was too high for the MuscleChip, due to the greater pro-
portion of "present" calls (e.g. the tissue-specific nature of
our chip) (Figure 1. Panel A). Consistent with previous re-
ports, the probe sets fulfilling all previously described
"rules" [4,10] performed most consistently.
We found relatively good correlation between hybridiza-
tion of cRNA from normal muscle (absolute intensities),
with cluster number (n-EST), both when analyzing all
probe sets (Figure 2, Panel A), and then a subset of probe
sets corresponding to low cluster number (singletons, du-
plex, and triplex clusters) (Figure 3, Panel A). Using all
probe sets, there was a correlation coefficient of 0.67 be-
tween cRNA hybridization and EST clone frequency in a
non-normalized cDNA library (Figure 2, Panel A). Neither
method is likely entirely representative of the true fre-
quency of each RNA species in normal tissue. EST clone
number is probably skewed by the fact that the RNA was
made from only a single individual (pectoral muscle from
a woman undergoing a mastectomy), resulting in mRNA
species differences due to polymorphic variability. The
difference in sensitivity between these two techniques
may contribute to lower the linear correlation, with corre-
lation coefficient of 0.6, obtained between the averaged
intensity value (intensity average from six individual pro-
files of normal adult muscle) and n-EST number (Figure
2, Panel B and Panel C). Also, while the cDNA was from
an older female, the muscle biopsies used for expression
profiling were all from males. Second, creation of cDNA
libraries may skew the frequency of specific cDNA clones
due to priming or cloning differences, or toxicity of certain
cDNA sequences to the prokaryotic host. Hybridization
intensities can vary due to differential cDNA synthesis, or
cRNA amplification of muscle RNA. Moreover, incorpora-
tion of biotin labels, and hybridization kinetics, can lead
to skewing of hybridization patterns. Given all these vari-
ables, the observed correlation of EST clone number in
each cluster, and hybridization intensities, was considered
encouraging.
One of the goals of this study using the MuscleChip was
to use the hybridization patterns of probe sets as a means
of confirming the expression in muscle of novel ESTs, and
thereby confirming the novel ESTs as "genes". This analy-
sis is particularly important when the EST clusters under
Table 3: Distribution of "present", "marginal" and "absent" calls 
for 195 _at "novel EST clusters"
# ESTs Abs Call % ESTs in cluster
n-EST = 2 (116 sequences)
50 P 43.1 %
2 M 1.7 %
64 A 55.2 %
n-EST = 3 (58 sequences)
39 P 67.2 %
3 M 5.2 %
16 A 27.6 %
n-EST = 4 (21 sequences)
16 P 76.2 %
1 M 4.8 %
4 A 19.0 %
Table 4: "Present" calls for probe sets representing novel 
sequences.
Probe sets representing 369 novel sequences 605
Number of "Present" calls for 605 probe sets 285
_at probe sets in 369 novel sequences 250
_at probe that were "Present" 114
Number of non verified non-hit _at only probe set 
sequences
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study contain one, or only a few, cluster members (e.g.
EST singletons). Such EST clusters with very low cluster
members are generally viewed with suspicion, even when
confirmed in genomic sequence, due to the possibility of
genomic contamination in cDNA libraries, the normaliza-
tion processes used for many cDNA library constructions,
and/or "illegitimate transcription" that could lead to se-
quencing of EST clones that are not truly "expressed" in
the tissue under study. An advantage of the MuscleChip is
that relatively large probe sets are designed against each
gene, typically containing 16 gene-specific perfect match
25 mers tiled against the 3' end of the mRNA/EST, and an
additional 16 paired mismatch probes with a single nucle-
otide change in the center of the oligo. This allows hybrid-
ization patterns across the entire probe set to be analyzed,
leading to a more quantitative and specific analysis of ex-
pression of the corresponding mRNA in the tissue. Three
different algorithms are used to analyze hybridization pat-
terns, and a threshold for each algorithm used to deter-
mine whether the corresponding cRNA is "present" or
"absent" in the RNA under study [4,10]. Using the default
algorithms and associated thresholds, we showed that
285 of 605 (47%) probe sets corresponding to 369 novel
EST clusters/singletons were determined to be expressed
("present") in normal muscle (Table 4). A number of
these probe sets did not fulfill all "rules", due to the limit-
Table 5: Novel sequences validated by BLAT search against theworking draft of the human genome at UCSC (only first page is shown, 
please go to Additional Files, File 1 to see the full table)
BLAST/BLAT 
query Acc
BAC-/Genomic-/mRNA-
clone
Hypothetical 
Protein 
mRNA (1)
Gene Prediction BLAT 1st 
Identity
BLAT 1st 
Chr.Hit
Average 
value of Avg 
Diff
Std. Dev. % P or M 33 
arrays
F15766 AL158039.5 NM_032728.1 A, E, F, G 97.8% 9q34.2 757 239 97.0%
F15804 AC002351.1 G 98.6% 12q24.11 1570 843 93.9%
F15913 AL357374.11 A, E, F, G 99.7% 20q11.22 1611 623 100.0%
F15967 AC008763.7 (XM_058961.1) A, E, F, G 98.2% 19p13.3 1125 285 100.0%
F16039 AP000348.1 (XM_059329.1 A, E, F, G 99.7% 22q11.23 6950 3513 100.0%
F16253 AC022307.14 NM_018045.1 A, F, G 99.1% 1p35.1 330 217 84.8%
F16384 AC096677.2 A 99.2% 1q32.3 1352 725 87.9%
F16396 AC092664.2 A 99.7% 2q13 2412 685 100.0%
F16592 AC023415.3 100.0% 13q31.2 882 614 100.0%
F16715 AL031727.42 (XM_059093.1) A 99.5% 1p36.13 2653 532 100.0%
F16733 AC092069.2 A, E, F, G 98.6% 19p13.2 549 139 97.0%
F16774 AC092636.3 A 100.0% 2q11.2 2061 1554 100.0%
F16938 AC021165.4 F, G 99.0% 19p13.3 1722 422 90.9%
F16970 AC068700.5 A 100.0% 8q21.13 333 195 90.9%
F17157 AL512652.18 A 98.1% 13q12.11 538 297 87.9%
F17214 BC015836 A 100.0% 3q25.2 4572 2296 100.0%
F17216 AP000512.1 G 98.2% 6p21.33 473 120 97.0%
F17258 AC005568.1 A 97.7% 16p13.3 2515 553 100.0%
F17715 AL353689.18 NM_020247.1 A, E, F 99.3% 1q42.13 2744 1124 100.0%
F17797 AC013603.14 NM_024025.1 A, E, F 96.1% 8p12 1236 635 100.0%
F18177 AC004643.1 NM_017885.1 A, E, F 99.5% 16p13.3 2164 900 100.0%
F18188 Z63603.1 A 99.1% 12q24.31 618 322 100.0%
F18468 AL138796.6 A, E 99.3% 1q21.1 8300 1981 100.0%
F18648 AC004985.2 (NM_032014.1) A, E, F, G 100.0% 7p13 2018 577 100.0%
F18791 AL359079.15 NM_017698.1 A, F 99.8% Xq23 598 194 78.8%
F18796 AC010271.7 A 98.6% 19q13.13 308 175 81.8%
F18838 AC011380.5 NM_032412.1 A 100.0% 5q31.3 1410 550 100.0%
F18952 AC027674.9 A 99.2% 10q11.22 1207 357 97.0%
F19033 AP003419.1 (XM_040083.1) A, E 100.0% 11q13.2 662 148 97.0%
F19110 AC079814.9 G 99.0% 3p21.31 14508 4317 100.0%
F19200 AB020863.1 A 100.0% 8p22 817 378 84.8%
F19351 AL590128.2 (AY037153.1) A, E 99.7% 1p36.31 2326 1581 75.8%
F20210 AL137281.1 A, G 98.1% 11q21 1641 913 100.0%
F20217 AC007687.16 A 100.0% 3q26.33 1009 774 93.9%
F20427 AP000803.2 A 100.0% 11q13.1 1022 367 75.8%
F20554 AL591408.3 NM_032747.1 E, F 99.1% 10q24.33 1770 442 100.0%
F20576 AC007225.2 A 99.8% 16q11.2 48 52 39.4%
F20639 AC004230.1 A 100.0% 11q11 3225 1134 100.0%
F20736 AC027674.9 A 100.0% 10q11.22 372 159 97.0%
(1) Entries in parentheses are hypothetical protein mRNA RefSeq hits found by BLAST to nr database (ENTREZ nucleotide database, NCBI) but 
not by BLAT-search in the Human Genome browser  [http://genome.ucsc.edu].BMC Bioinformatics 2002, 3 http://www.biomedcentral.com/1471-2105/3/33
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ing amount of sequence data available for EST singletons;
limiting the analysis to ideal _at probe sets showed that
114 of 250 (46%) probe sets corresponding to novel EST
clusters were "present" in 4 out of 4 control profiles (Ta-
bles 4), and 157 of 250 (63%) were "present" in 1 control
out of 4 profiles (data not shown). We further limited the
study set to 369 of the original 734 novel ESTs, which by
recent BLAST update (March 2002) showed no high simi-
larity to a characterized gene, according to the thresholds
described in Methods. The 369 ESTs are represented by
605 probe sets on the MuscleChip, of which 250 are ideal
_at probe sets. Of the 114 probe sets that were validated
by "present" calls in four out of four pooled controls (Ta-
ble 4), 102 showed similarity to genomic, mRNA (RefSeq
database) or hypothetical protein.
To anchor the transcript units on the human genome se-
quence, we used the sequences of 102 "present" ESTs in a
BLAT search against the human genome draft sequence
(Table 5, [12,13]). The BLAT search resulted in significant
alignment to "translated RNA" sequence in 40 of the cases
(35%) and to genomic DNA in all but two cases. Two ESTs
did not match any part of the draft sequence, although a
significant alignment to IMAGE mRNA clones from the nr
database at NCBI base was verified. Both ESTs showed rel-
atively low average intensities in 33 MuscleChip experi-
ments; however 89% and 100% of the profiles showed
"present" calls for the two ESTs respectively (Table 5).
The 102 expression validated novel ESTs represent 0.31%
of the ~33,000 genes on the new human genome HG-
U133 Affymetrix array set. The HG-U133A and HG-
U133B array together have approximately 44,000 probe
sets querying about 33,000 unique genes/ESTs. We have
found that the HG-U133A has a sensitivity to muscle of
40–45% "present" calls, corresponding approximately
9,000 to 10,000 probe sets, and the HG-U133B shows a
sensitivity of 15–20% "present" calls, corresponding to
approximately 3,800 probe sets, which in combination
gives approximately 13,000 transcripts. Thus, the 102 un-
characterized or novel ESTs represent ~0.75% of tran-
scribed muscle genes that are not represented on the stock
arrays.
Conclusion
We have designed a muscle specific oligonucleotide chip
containing 4,601 probe sets representing 3,344 unique
genes/ESTs. The performance of the MuscleChip was vali-
dated by comparison of shared probe sets from expression
profiles to HG-U95A stock chip. This comparison showed
a linear correlation of intensities between the two types of
arrays, although the MuscleChip was shown to have a
higher dynamic range of intensities before reaching the
saturation level.
The MuscleChip was used to validate ESTs from a non-
normalized cDNA library of human muscle. Correlation
of intensity values from the MuscleChip expression pro-
files with EST clone number in each EST cluster showed a
correlation coefficient between 0.60 and 0.67 when re-
stricting the analysis to probe sets fulfilling all probe de-
sign rules and representing only unique transcripts (_at
probe sets).
Furthermore, we have shown that the MuscleChip can be
used as a means of confirming the expression in muscle of
novel ESTs, and thereby confirming the novel ESTs as
"genes". We found 102 EST clusters to be expressed in hu-
man muscle, transcriptionally validated by 33 Muscle-
Chip expression profiles, and genome-anchored by BLAST
or BLAT search to the Human Genome sequence. 40 of the
ESTs clusters were furthermore verified by alignment to
potential transcriptional units in the RefSeq database.
Methods
Sequence definitions for MuscleChip
The MuscleChip was designed to contain 4,601 probes
representing 3,344 sequences from four different sources.
2,052 sequences were from EST clusters from a non-nor-
malized skeletal muscle sequencing project [7] (see  [ht-
tp://muscle.cribi.unipd.it] for description of the muscle
EST sequencing project), 1,052 sequences from the HG-
U95A Affymetrix stock chip, 68 sequences were from the
HuFL array (the first edition human Affymetrix stock
chip), and 172 sequences were of special interest to the
laboratory (see  [http://microarray.cnmcresearch.org/
musclechipindex.asp] for spreadsheets (MuscleChip EA-
SI) of all gene/EST names, accession numbers, and probe
set designators, and (MuscleChip Probe Sequences) file
for the sequences of all probe sets used). The MuscleChip
was designed to be highly redundant, both between the
commercial GeneChip and the custom MuscleChip, and
within the MuscleChip itself, with many ESTs being repre-
sented by multiple probe sets (Table 1). This was done to
facilitate validation of the MuscleChip. The 1,120 se-
quences from HG-U95A and HuFL respectively are catego-
rized as "commercial sequences" and are represented on
the MuscleChip with the same probes as on the Affymetrix
stock chips. In order to select the commercial probes,
eight expression profiles were generated using biopsies
from five male patients with primary dystrophinopathy
(Duchenne Muscular Dystrophy, DMD), four patients
(two male and two female) with α-sarcoglycan dystrophy
(α-SG), and five age-matched male controls (Con) as pre-
viously described [8] with an additional two profiles from
five female age-matched controls (ConF; data not shown).
Probe sets that were assigned a "present" call, showed dif-
ferential expression in comparative analysis (assigned a
diff call by Affymetrix GeneChip software [10]), and had
an average fold change greater than 2.0 were consideredBMC Bioinformatics 2002, 3 http://www.biomedcentral.com/1471-2105/3/33
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for inclusion on the MuscleChip. Duplicate records were
removed, as was overlap with the custom EST sequences,
resulting in 1,052 (of 5,513 tested on the HuFL Chip)
commercial sequences selected for representation on the
MuscleChip. Due to the upgrade from HuFL to HG-U95A
(Human Genome Unigene 95 build), which resulted in
new probe designs for some sequences, new probe sets on
the HG-U95A array (16 probe pairs per probe set) were
picked to replace each HuFL probe set (20 probe pairs per
probe set). We used a subtracted non-normalized human
muscle EST database with 28,074 sequenced ESTs ([7] and
unpublished data) to design and print probe sets corre-
sponding to 2,052 EST clusters (1,341 defined genes, and
734 undefined ESTs). ESTs were from the 3'end of the cor-
responding mRNAs. The library was subtracted using a fil-
ter hybridization procedure to identify and remove the 10
most abundant mRNAs in the library, in order to mini-
mize the number of redundant transcripts to sequence [7].
The 10 genes used for the filter hybridization were identi-
fied from a preliminary sequencing of 1,054 randomly se-
lected EST clones [7]. These 10 most abundant transcripts
accounted for more than 45% of the clones in the non-
normalized library. 28,074 additional clones were se-
quenced after subtraction, clustered using TIGR Assem-
bler program, compared to the Unigene 90 build for gene
identification (>95% identity for a match assignment),
and then manually checked for incorrect clustering or se-
quence identities. Out of the 2,052 EST clusters represent-
ed on the MuscleChip, 734 represented clusters that had
shown no identity to previously characterized clusters or
genes in the Unigene build 90 (Table 1). These 734 clus-
ters showed EST member numbers varying from 1 to 579
(n-EST = 1 to n-EST = 579). To update the probe descrip-
tions, and also to correct for inappropriately defined sin-
gletons by the Assembler program [9], we tested the
consensus sequence for each of the 734 previously unde-
fined ESTs against Unigene 2002 builds using Netblast cl3
(Table 2). A query sequence was defined to have a low sig-
nificant match (hit) for alignments with identities < 100
bp and a significant match for alignments with identities
> 100 bp. A match was considered indicative of identity
with the search sequence when E-score < 10-60, indicative
of similarity to the search sequence when 10-60 < E-score
< 10-34, and to show no high similarity when E >10-34.
New gene definitions were found for 365 of the 734 EST
clusters in Unigene and RefSeq, leaving 369 as undefined,
novel EST clusters (Table 2).
A list of all genes, EST clusters, and accession numbers is
available on our web site ( [http://microarray.cnmcre-
search.org/musclechipindex.asp].
MuscleChip production
Probe sets were chosen from the 650 base pairs at the 3'
end of each gene or consensus sequence. Sixteen 25-mers
covering a total of 400 bp were selected and aligned
against all other probes represented on Affymetrix stock
arrays in order to prune the dataset and to give a "meas-
ure" of similarity and identity among Affymetrix Human
Genome probe sets (~70,000). Furthermore, each probe
set was characterized according to the type of sequence it
"describes" by an identifying underscore label (_at, _s, _g,
_f, _r, and _i; EASI™ Expression Analysis Sequence Infor-
mation Database). All probe sets on Affymetrix chips are
synthesized in the sense orientation, and the target cRNA
in anti-sense orientation (indicated by the _at label on
probe sets). If no additional underscore label has been as-
signed, the probe set corresponds to a single gene or the
consensus sequence of a cluster of sequences (ESTs). For
probe sets that could potentially cross-hybridize to a small
number of sequences, a similarity constraint (_s) was as-
signed. For probe sets corresponding to one or more EST
clusters that were similar but not identical (including pol-
ymorphisms, clusters of genes or ESTs, overlapping and
non-overlapping) or from regions where it was not possi-
ble to pick a full probe set (16 probes), a _f (for sequence
family) or a _g (for common groups) was assigned. For
EST clusters where the number of cluster members was
only one (singletons), or other low numbers, then re-
straints on the amount and accuracy of sequence data
available often forced use of non "ideal" probe sets. In
these cases it was not possible to design a unique set of
probes while applying all Affymetrix probe rules. Such
probe sets were assigned a _r (rules dropped) or _i (in-
complete) designator if there were fewer than 15 probes in
the probe set. Of the 369 novel EST clusters printed on the
chip, only 250 (68%) were represented by at least one _at
probe set on the MuscleChip (see Results).
In total, approximately 75,000 perfect match probes and
~75,000 mismatch probes were synthesized by photoli-
thography and photo-activated chemistry using 24 µm2
features. Chips were synthesized on 90 chip wafers, then
divided and packaged into standard Affymetrix GeneChip
format.
RNA isolation, cRNA production
RNA isolation, purification, cDNA production, and syn-
thesis of biotinylated cRNA were as previously described
[8]. Quality control measures for cRNA and chip hybridi-
zation are provided on our web site  [http://microar-
ray.cnmcresearch.org/pgaoutline-qcofsamples.asp].
Data analysis
The data analysis of the arrays was done using the stand-
ard metrics as implemented in Affymetrix MicroArray
Suite 4.0 [4,10]. Briefly, the hybridization signal for each
sequence is queried by probe sets of 16 probe pairs (a 25-
mer perfect match (PM), and a 25-mer mismatch probe
(MM)). Using the Affymetrix metrics, an absolute intensi-BMC Bioinformatics 2002, 3 http://www.biomedcentral.com/1471-2105/3/33
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ty (normalized hybridization intensity) and an absolute
call ("present", "absent" or "marginal") was assigned to
each probe set. The absolute intensity, in Affymetrix ter-
minology called the Average Difference (Avg Diff), is the
average value of the PM minus the MM in each probe pair
in a probe set. By combining three standard algorithms
used to calculate values for the internal ratios of PM to
MM to signal strength in each probe pair, the absolute call
of "absent", "marginal" or "present" is assigned based on
whether or not any one of the three algorithms meet
threshold values (Affymetrix MicroArray Suite 4.0 User
Guide).
Validation of non-characterized ESTs
In order to validate the ESTs represented on the chip
(2,052 probe sets), the ESTs were grouped and ranked ac-
cording to the number of sequences that constituted each
particular EST cluster, with the number of ESTs ranging
from 1 (n-EST = 1) to 579 (n-EST = 579). To determine the
distribution of absolute intensities within each of the 96
EST clusters (1 to 579 ESTs in each cluster), we designed a
program in C++ called "Vertical Line" that can be used to
visualize the absolute intensity as well as the absolute call,
using a variety of color-coding schemes. The program is
available on our website  [http://microarray.cnmcre-
search.org/resources.htm], click "vertical line executable"
to save an executable of the program.
To assign higher confidence to the set of 369 EST clusters
that showed no high similarity to genes with known name
or function by BLAST search to the non redundant (nr) se-
quence database at NCBI, the 250 ESTs associated with _at
only probe set were filtered by "present" call in all of four
pooled normal muscle [8]. Of the 114 ESTs that were se-
lected, the 102 that showed similarity to genomic, mRNA,
or hypothetical protein (RefSeq) by BLAST search, were
BLAT searched against the Human Genome draft se-
quence using the UCSC Human Genome Project Working
Draft,  [http://www.genome.ucsc.edu/][12,13]. BLAT
alignments of length greater than 40 bases and identity
higher than 95% are defined as a match [12]. For each EST
query, the accession number of the best BLAT alignment
to genomic and mRNA sequence is shown along with the
chromosome match and percentage of identity for both
the best and the next best alignments (Table 5). In the cas-
es when the original EST BLAST hit were a genomic se-
quence, the hit was retained only if it was identical to the
BLAT alignment, otherwise the accession number shown
in the BAC-/ Genomic-/ mRNA-clone column is for the
best genomic DNA BLAT hit (Table 5). In the other cases
where the best original BLAST hit was a hypothetical gene
or protein, the accession number is shown next to the ge-
nomic BLAT accession. Entries in parentheses are hypo-
thetical protein mRNA RefSeq hits found by BLAST to nr
database (ENTREZ nucleotide database, NCBI) but not by
BLAT-search in the Human Genome browser [12,13].
When any of four gene prediction programs predicted an
open reading frame or exon in the region of the human
genome sequence that overlapped with the EST align-
ment, letter codes corresponding to the particular pro-
gram used is shown in the table. An Assembly gene
prediction is defined by A. Ensembl gene prediction by E,
FgenesH++ prediction by F and GenScan gene predictions
by G. See Additional File 1 for excel-sheet version of Table
5 containing additional results on next best BLAT hits and
direct hotlink to ENTREZ nucleotide database, NCBI.
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